Explore 3 Stock Ideas & Industry Insights Download Free Report

Stryker Corporation

Company price
310.55 USD 3.74 ( 1.22%)
Last update at 2026-11-03T21:00:00Z
VOLUME
2585825
Market Cap
107975.82M
P/E
29.23

Momentum Score

…

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
306.41
Low
312.74
High
52 Week Price Range
267.00
Low
389.48
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
306.81
Dividend Yield
1.23%
Revenue TTM
25837.00M
Revenue Per Share
67.50
Gross Profit TTM
16946.00M
Debt / Equity
0.73
ROE
16.51%
Net Debt
12349.00M
ROCE
12.79%
Diluted EPS TTM
9.63

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 4514.00M 3492.00M 3673.00M 2683.00M 2281.00M
Net income 3246.00M 2993.00M 3165.00M 2358.00M 1994.00M
Selling general administrative 8221.00M 7685.00M 7129.00M 6035.00M 5752.00M
Gross profit 16065.00M 13980.00M 12494.00M 11578.00M 10968.00M
Reconciled depreciation 1193.00M 1050.00M 1028.00M 998.00M 990.00M
Ebit 5121.00M 3888.00M 4029.00M 2841.00M 2584.00M
Ebitda 6314.00M 4938.00M 5057.00M 4241.00M 3780.00M
Depreciation and amortization 1193.00M 1050.00M 1028.00M 1400.00M 1196.00M
Non operating income net other - - - -158.00M -303.00M
Operating income 4889.00M 5061.00M 4281.00M 2841.00M 2584.00M
Other operating expenses 20227.00M 17534.00M 16217.00M 15407.00M 14421.00M
Interest expense 607.00M 396.00M 356.00M 158.00M 509.00M
Tax provision 1268.00M 499.00M 508.00M 325.00M 287.00M
Interest income 486.00M 257.00M 281.00M 243.00M 269.00M
Net interest income -607.00M -409.00M -363.00M - -
Non recurring - - - 216.00M -
Income tax expense 1268.00M 499.00M 508.00M 325.00M 287.00M
Total revenue 25116.00M 22595.00M 20498.00M 18449.00M 17108.00M
Total operating expenses 11176.00M 8919.00M 8213.00M 8536.00M 8281.00M
Cost of revenue 9051.00M 8615.00M 8004.00M 6871.00M 6140.00M
Total other income expense net -375.00M -1569.00M -608.00M -158.00M -303.00M
Net income from continuing ops 3246.00M 2993.00M 3165.00M 2358.00M 1994.00M
Net income applicable to common shares 3246.00M 2993.00M 3165.00M 2358.00M 1994.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 47844.00M 42971.00M 39912.00M 36884.00M 34631.00M
Intangible assets 5681.00M 4395.00M 4593.00M 4885.00M 4840.00M
Other current assets 1306.00M 1684.00M 857.00M 787.00M 662.00M
Total liab 25424.00M 22337.00M 21319.00M 20268.00M 19754.00M
Total stockholder equity 22420.00M 20634.00M 18593.00M 16616.00M 14877.00M
Other current liab 4842.00M 3989.00M 3776.00M 3699.00M 3413.00M
Common stock 38.00M 38.00M 38.00M 38.00M 38.00M
Capital stock 38.00M 38.00M 38.00M 38.00M 38.00M
Retained earnings 20472.00M 18528.00M 16771.00M 14765.00M 13480.00M
Other liab - - - 1751.00M 2733.00M
Good will 19291.00M 15855.00M 15243.00M 14880.00M 12918.00M
Other assets 4241.00M 3910.00M 3849.00M 3874.00M 4023.00M
Cash 4011.00M 3652.00M 2971.00M 1844.00M 2944.00M
Cash and equivalents 4011.00M 3652.00M 2971.00M 1844.00M 2944.00M
Total current liabilities 7794.00M 7616.00M 7921.00M 6303.00M 4549.00M
Current deferred revenue - - 1551.00M - -
Net debt 12349.00M 9945.00M 10523.00M 11204.00M 9528.00M
Short term debt 1153.00M 1409.00M 2237.00M 1191.00M 7.00M
Short long term debt 1000.00M 1409.00M 2094.00M 1191.00M 7.00M
Short long term debt total 16360.00M 1409.00M 13494.00M 13048.00M 12472.00M
Other stockholder equity 2597.00M 2361.00M 2200.00M 2034.00M 1890.00M
Property plant equipment 3876.00M 3964.00M 3709.00M 2970.00M 2833.00M
Total current assets 14755.00M 14847.00M 12518.00M 10275.00M 10017.00M
Net tangible assets - - - -3149.00M -2881.00M
Short term investments 89.00M 750.00M 82.00M 84.00M 75.00M
Net receivables 4039.00M 3987.00M 3765.00M 3565.00M 3022.00M
Long term debt 14859.00M 12188.00M 10901.00M 11857.00M 12472.00M
Inventory 5310.00M 4774.00M 4843.00M 3995.00M 3314.00M
Accounts payable 1799.00M 1679.00M 1517.00M 1413.00M 1129.00M
Accumulated other comprehensive income -687.00M -293.00M -416.00M -221.00M -531.00M
Common stock total equity - - - 38.00M 38.00M
Retained earnings total equity - - - 14765.00M 13480.00M
Non currrent assets other 2622.00M 2684.00M 2177.00M 2464.00M 2263.00M
Non current assets total 33089.00M 28124.00M 27394.00M 26609.00M 24614.00M
Long term debt total 14859.00M 12188.00M 10901.00M 11857.00M 12472.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 750.00M -3000.00M -972.00M -2924.00M -859.00M
Change to liabilities - - - 223.00M 325.00M
Total cashflows from investing activities -4866.00M -3000.00M -962.00M -2924.00M -859.00M
Net borrowings 1579.00M 940.00M -277.00M 472.00M -1153.00M
Total cash from financing activities 113.00M -525.00M -1594.00M -749.00M -2365.00M
Change to operating activities - - - 64.00M 279.00M
Net income 3246.00M 2993.00M 3165.00M 2358.00M 1994.00M
Change in cash 359.00M 681.00M 1127.00M -1100.00M 1.00M
Begin period cash flow 3652.00M 2971.00M 1844.00M 2944.00M 2943.00M
End period cash flow 4011.00M 3652.00M 2971.00M 1844.00M 2944.00M
Total cash from operating activities 5044.00M 4242.00M 3711.00M 2624.00M 3263.00M
Depreciation 1193.00M 1050.00M 1028.00M 998.00M 990.00M
Other cashflows from investing activities -60.00M 43.00M 1.00M -2336.00M 5.00M
Dividends paid 1284.00M 1219.00M 1139.00M 1051.00M 950.00M
Change to inventory -297.00M -206.00M -797.00M -762.00M -189.00M
Change to account receivables 127.00M -321.00M -175.00M -579.00M -377.00M
Sale purchase of stock -149.00M -195.00M -155.00M - 0.00M
Other cashflows from financing activities -33.00M -51.00M -23.00M 955.00M -264.00M
Change to netincome - - - 454.00M 464.00M
Capital expenditures 761.00M 755.00M 575.00M 588.00M 525.00M
Change receivables - - - -579.00M -377.00M
Cash flows other operating - - - -68.00M 56.00M
Cash and cash equivalents changes - - - -1049.00M 39.00M
Change in working capital -373.00M -683.00M -500.00M -732.00M 279.00M
Stock based compensation 243.00M 229.00M 205.00M 168.00M 171.00M
Other non cash items 343.00M 1023.00M 19.00M -226.00M 66.00M
Free cash flow 4283.00M 3487.00M 3136.00M 2036.00M 2738.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SYK
Stryker Corporation
3.74
1.22%
310.55 29.23 16.86 4.18 4.51 4.63 17.16
ABT
Abbott Laboratories
-
-%
109.40 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-0.41
0.41%
98.88 26.60 15.87 3.35 2.08 3.90 14.12
SEMHF
Siemens Healthineers AG
0.66
1.38%
48.35 39.57 21.32 3.01 3.29 2.95 16.92
SMMNY
Siemens Healthineers AG ADR
-0.14
0.58%
24.12 39.49 21.10 3.01 3.25 2.95 16.92

Profile*

Stryker Corporation

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

1941 Stryker Way, Portage, MI, United States, 49002

(269) 385-2600

56000

Name Title Year Born
Mr. Kevin A. Lobo Chairman, CEO & Pres 1965
Mr. Glenn S. Boehnlein VP & CFO 1962
Mr. Timothy John Scannell Exec. Advisor 1965
Mr. Viju S. Menon Group Pres of Global Quality & Operations 1968
Mr. J. Andrew Pierce Group Pres of MedSurg & Neurotechnology 1974
Mr. Spencer S. Stiles Group Pres of Orthopaedics & Spine 1977
Mr. William E. Berry Jr. VP & Chief Accounting Officer 1966
Mr. Robert C. Cohen CTO and VP of Global R&D - Joint Replacement NA
Mr. Alan Douville VP, Chief Information Officer & Chief Information Security Officer NA
Mr. Jason Beach VP of Investor Relations NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…